Skip to main content
Premium Trial:

Request an Annual Quote

Lion to Integrate Electric Genetics Clustering Tool in SRS Software

MIAMI, Sept 12 – Lion Bioscience (Nasdaq: LEON, Neuer Markt: LIO) of Heidelberg , Germany said Tuesday it would incorporate Electric Genetics’ expressed sequence tags clustering tool into its SRS data integration platform, representing a vote of confidence for the South African startup.

Until now, Lion has distributed Electric Genetics’ stackPACK software but this is the first software integration deal the companies have signed.

"We decided to partner with them to include their solution in our integration system because this way we’re a lot quicker than if we had to invent it on our own," Andrea Kreisselmeier, head of marketing and communications at Lion, told GenomeWeb ahead of the Genome Sequencing and Analysis Conference.

The companies declined to disclose the terms of the deal.

Tania Broveak Hide, managing director at Cape Town-based Electric Genetics, said that by incorporating the clustering tools, the companies could provide scientists with a software package that would help them to speed up the data analysis procedure.

"This will get researchers on the annotation road more quickly," she said.

SRS, a data integration software, is able to pool information from more than 400 public and private databases and applications in the life science industry.

StackPACK enables the clustering, alignment, and analysis of high volumes of ESTs and partial length sequences into maximal length transcripts.

Kresselmeier said that the companies would jointly market the integrated product, which they expect to release in the near future.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more